Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adam J. Townsend Insider Profile
4 Followers
Adam J. Townsend, CCO at Apellis Pharmaceuticals, holds 88.07K shares in Apellis Pharmaceuticals (Ticker: APLS). Most recently, Adam J. Townsend Sold $2,201 shares of Apellis Pharmaceuticals on Jan 21, 2025 for an estimated value of 65.92K.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+57.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Adam J. Townsend's holdings
Insider Roles
CCO
Roles that Adam J. Townsend holds in companies
Most Profitable Insider Trade
The most profitable trade made by Adam J. Townsend
Adam J. Townsend's Trading History
List of latest transactions for each holding click on a transaction to see Adam J. Townsend's performance on stock
You May Also Like
Adam J. Townsend insider profile FAQ
What is the percentage of profitable transactions made by Adam J. Townsend?
The percentage of profitable transactions made by Adam J. Townsend is 100%.
What is the average return per transaction made by Adam J. Townsend?
The average return per transaction made by Adam J. Townsend is 57.90%.
What stocks does Adam J. Townsend hold?
Adam J. Townsend holds: APLS stocks.
What was Adam J. Townsend’s latest transaction?
Adam J. Townsend latest transaction was an Informative Sell of $65.92K.
What was Adam J. Townsend's most profitable transaction?
Adam J. Townsend’s most profitable transaction was an Informative Sell of APLS stock on January 23, 2024. The return on the trade was 58.50%.
What is Adam J. Townsend's role in Apellis Pharmaceuticals?
Adam J. Townsend's role in Apellis Pharmaceuticals is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.